Drug Trial Radar · NCT03127267
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Last checked: Nov 19, 2026Latest source record: Sep 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
495
Planned (sponsor's estimate)
Start
Feb 2, 2021
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- AB ScienceIndustry
- Sponsor type
- Industry
- First posted
- Apr 25, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 81 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective is to compare the efficacy and safety of masitinib in combination with riluzole versus matched placebo in combination with riluzole for the treatment of Amyotrophic Lateral Sclerosis (ALS).
Conditions
- Amyotrophic Lateral Sclerosis
Interventions
Masitinib (6.0)Drug
Masitinib (titration to 6.0 mg/kg/day)
RiluzoleDrug
Riluzole 50 mg tablet, treatment per os
PlaceboDrug
treatment per os
Masitinib (4.5)Drug
Masitinib (titration to 4.5 mg/kg/day)
Primary outcomes
What the sponsor says the trial is designed to measure.
- ALSFRS-RTime frame: 48 weeks
Locations
56 sites in 17 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
University of Southern California
Los Angeles, California · Recruiting
University of Kentucky
Lexington, Kentucky · Recruiting
Johns Hopkins Medicine Brain Science Institute
Baltimore, Maryland · Recruiting
Lahey Hospital and Medical Center
Burlington, Massachusetts · Recruiting
University of Virginia Health System
Charlottesville, Virginia · Recruiting
University Hospital Leuven (UZ Leuven)
Leuven, Belgium · Recruiting
Bispebjerg Hospital
Copenhagen, Denmark · Recruiting
CHU de Angers
Angers, France · Recruiting
Groupe Hospitalier Pellegrin Tripode
Bordeaux, France · Recruiting
Hôpital neurologique Pierre Wertheimer
Bron, France · Recruiting
CHU Gabriel Montpied
Clermont-Ferrand, France · Recruiting
CHU de Lille - Hopital Roger Salengro
Lille, France · Recruiting
CHU de Limoges - Hôpital Dupuytren
Limoges, France · Recruiting
CHU de Marseille - Hôpital de la Timone
Marseille, France · Recruiting
CHRU de Montpellier - Gui de Chauliac
Montpellier, France · Recruiting
CHU de Nancy - Hopital Central
Nancy, France · Recruiting
CHU Hôpital Pasteur Nice
Nice, France · Recruiting
CHRU de Tours - Hopital Bretonneau
Tours, France · Recruiting
Department of Neurology, University of Ulm
Ulm, Germany · Not yet recruiting
Athens Naval Hospital
Athens, Greece · Recruiting
Eginition Hospital
Athens, Greece · Recruiting
University General Hospital of Larissa
Larissa, Greece · Recruiting
General University Hospital of Patras
Rio, Greece · Recruiting
Hadassah University Hospital
Jerusalem, Israel · Recruiting
Tel-Aviv Medical Center Hôpital Sourasky (ICHILOV)
Tel Aviv, Israel · Recruiting
ASST degli Spedali Civili di Brescia
Brescia, Italy · Recruiting
Centro Clinico NeMO Fondazione Serena Onlus
Gussago, Italy · Recruiting
Clinico Nemo Center (Centro Clinico NeMO Milano)
Milan, Italy · Recruiting
IRCCS Istituto Auxologico Italiano
Milan, Italy · Recruiting
Istituti Clinici Scientifici Maugeri IRCCS
Milan, Italy · Recruiting
San Raffaele Hospital (Ospedale San Raffaele)
Milan, Italy · Recruiting
University Hospital Maggiore della Carita
Novara, Italy · Recruiting
Azienda Ospedale-Università Padova
Padova, Italy · Recruiting
IRCCS Mondino Foundation
Pavia, Italy · Recruiting
University Hospital in Turin (Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino)
Torino, Italy · Recruiting
Ospedale Civile Sant'Agostino - Estense
Baggiovara, Modena, Italy · Recruiting
Oslo University Hospital HF Ullevål
Oslo, Norway · Recruiting
Centrum Medyczne Neuromed
Bydgoszcz, Poland · Recruiting
Hospital de Santa Maria
Lisbon, Portugal · Recruiting
Showing 40 of 56 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.